216 related articles for article (PubMed ID: 37093245)
41. Cutaneous b-cell lymphomas of follicular and marginal zone types: use of Bcl-6, CD10, Bcl-2, and CD21 in differential diagnosis and classification.
de Leval L; Harris NL; Longtine J; Ferry JA; Duncan LM
Am J Surg Pathol; 2001 Jun; 25(6):732-41. PubMed ID: 11395550
[TBL] [Abstract][Full Text] [Related]
42. Differential survival of systemic B-cell lymphomas initially diagnosed in the skin: a population-based study of 883 patients.
Goyal N; Rubin N; Goyal A
Arch Dermatol Res; 2023 Mar; 315(2):259-263. PubMed ID: 34779893
[TBL] [Abstract][Full Text] [Related]
43. Flow cytometric expression of CD71, CD81, CD44 and CD39 in B cell lymphoma.
Espasa A; Tapia G; Vergara S; Raya M; Juncà J; Sorigue M
Scand J Clin Lab Invest; 2021 Sep; 81(5):413-417. PubMed ID: 34057378
[TBL] [Abstract][Full Text] [Related]
44. Clinical Significance of VEGF-A and Microvessel Density in Diffuse Large B-Cell Lymphoma and Low-Grade Follicular Lymphoma.
Shahini L; Gašparov S; Petruševska G; Manxhuka Kerliu S; Veselaj F; Kurshumliu F; Kavaja F
Acta Clin Croat; 2017 Dec; 56(4):588-593. PubMed ID: 29590710
[TBL] [Abstract][Full Text] [Related]
45. [Immunohistochemical patterns of follicular dendritic cell meshwork and Ki-67 in small B-cell lymphomas].
Shi YF; Li XH
Zhonghua Bing Li Xue Za Zhi; 2013 Apr; 42(4):222-6. PubMed ID: 23928527
[TBL] [Abstract][Full Text] [Related]
46. Lymphoma of the Eyelid - An International Multicenter Retrospective Study.
Svendsen FH; Rasmussen PK; Coupland SE; Esmaeli B; Finger PT; Graue GF; Grossniklaus HE; Honavar SG; Khong JJ; McKelvie PA; Mulay K; Ralfkiaer E; Sjö LD; Vemuganti GK; Thuro BA; Curtin J; Heegaard S
Am J Ophthalmol; 2017 May; 177():58-68. PubMed ID: 28209503
[TBL] [Abstract][Full Text] [Related]
47. Immunohistochemical Expression of Lymphoid Enhancer Binding Factor 1 in CD5-Positive Marginal Zone, Lymphoplasmacytic, and Follicular Lymphomas.
Patel N; Durkin L; Bodo J; Hsi ED
Am J Clin Pathol; 2020 Apr; 153(5):646-655. PubMed ID: 31953940
[TBL] [Abstract][Full Text] [Related]
48. [Cutaneous lymphomas : Clinical presentation - diagnosis - treatment].
Wobser M; Goebeler M
Pathologe; 2020 Feb; 41(1):79-94. PubMed ID: 31932947
[TBL] [Abstract][Full Text] [Related]
49. Low-Grade Primary Splenic CD10-Positive Small B-Cell Lymphoma/Follicular Lymphoma.
Abdulbaki R; Tizro P; Nava VE; Gomes da Silva M; Ascensão JL
Curr Oncol; 2021 Nov; 28(6):4821-4831. PubMed ID: 34898578
[TBL] [Abstract][Full Text] [Related]
50. Cytology and immunophenotyping of low- and intermediate-grade B-cell non-Hodgkin's lymphomas with a predominant small-cell component: a study of 56 cases.
Chhieng DC; Cohen JM; Cangiarella JF
Diagn Cytopathol; 2001 Feb; 24(2):90-7. PubMed ID: 11169886
[TBL] [Abstract][Full Text] [Related]
51. Pathology and diagnosis of follicular lymphoma and related entities.
Randall C; Fedoriw Y
Pathology; 2020 Jan; 52(1):30-39. PubMed ID: 31791624
[TBL] [Abstract][Full Text] [Related]
52. Classifications of cutaneous lymphomas and lymphoproliferative disorders: An update from the EORTC cutaneous lymphoma histopathology group.
Kempf W; Mitteldorf C; Cerroni L; Willemze R; Berti E; Guenova E; Scarisbrick JJ; Battistella M
J Eur Acad Dermatol Venereol; 2024 Apr; ():. PubMed ID: 38581201
[TBL] [Abstract][Full Text] [Related]
53. [Introduction on the update of the 5th edition WHO classifications of B-cell neoplasms].
Rao HL; Wang Z
Zhonghua Bing Li Xue Za Zhi; 2024 Jan; 53(1):6-11. PubMed ID: 38178739
[TBL] [Abstract][Full Text] [Related]
54. B-cell Non-Hodgkin Lymphomas with Plasmacytic Differentiation.
Harmon CM; Smith LB
Surg Pathol Clin; 2016 Mar; 9(1):11-28. PubMed ID: 26940265
[TBL] [Abstract][Full Text] [Related]
55. [Grey zone lymphomas: limitations of the classification of aggressive B-cell lymphomas].
Ott MM; Horn H; Rosenwald A; Ott G
Pathologe; 2013 May; 34(3):225-32. PubMed ID: 23494279
[TBL] [Abstract][Full Text] [Related]
56. Marginal zone B-cell lymphoma: A clinical comparison of nodal and mucosa-associated lymphoid tissue types. Non-Hodgkin's Lymphoma Classification Project.
Nathwani BN; Anderson JR; Armitage JO; Cavalli F; Diebold J; Drachenberg MR; Harris NL; MacLennan KA; Müller-Hermelink HK; Ullrich FA; Weisenburger DD
J Clin Oncol; 1999 Aug; 17(8):2486-92. PubMed ID: 10561313
[TBL] [Abstract][Full Text] [Related]
57. Pathology of follicular lymphoma.
Takata K; Miyata-Takata T; Sato Y; Yoshino T
J Clin Exp Hematop; 2014; 54(1):3-9. PubMed ID: 24942941
[TBL] [Abstract][Full Text] [Related]
58. Prognostic assessment in patients with indolent B-cell lymphomas.
Arcaini L; Rattotti S; Gotti M; Luminari S
ScientificWorldJournal; 2012; 2012():107892. PubMed ID: 22919288
[TBL] [Abstract][Full Text] [Related]
59. Significance of C4d deposition in the follicular lymphoma and MALT lymphoma and their relationship with follicular dendritic cells.
Bu X; Zheng Z; Wang C; Yu Y
Pathol Res Pract; 2007; 203(3):163-7. PubMed ID: 17307308
[TBL] [Abstract][Full Text] [Related]
60. The many faces of small B cell lymphomas with plasmacytic differentiation and the contribution of MYD88 testing.
Swerdlow SH; Kuzu I; Dogan A; Dirnhofer S; Chan JK; Sander B; Ott G; Xerri L; Quintanilla-Martinez L; Campo E
Virchows Arch; 2016 Mar; 468(3):259-75. PubMed ID: 26454445
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
